Lung transplants not dangerous for children with cystic fibrosis, after all

Responding to a study published in the New England Journal of Medicine, which concluded that lung transplants were harmful for children with cystic fibrosis, articles published in the latest issue of Pediatric Transplantation refute the conclusions and argue that the highly influential research was severely flawed.

According to two rebuttals published in the acclaimed journal, the conclusions of the study on post-transplant survival rates led by Theodore G. Liou, M.D., of the University of Utah, Salt Lake City, were seriously flawed by misinterpreted statistics that created a strong bias against transplantation.

“Dr. Liou, et al. are accomplished statisticians and honorable academicians,” says Thomas M. Egan, M.D., of the University of North Carolina at Chapel Hill in his systematic rejection of the study. “But sometimes statistics do not tell the truth.”

Using covariates obtained up to three years before actual transplantation and when predicted survival was good, the calculated hazard ratios Liou’s study put forth were based on outdated information that did not reflect true benefit on a patient-by-patient basis at the time of actual transplant, contend Egan and Stuart C. Sweet, M.D. of Washington University, St. Louis.

Liou’s study also conflicts with findings from other sources, in which survival rates for pediatric CF lung transplant recipients were substantially higher. Furthermore, recent changes in the U.S. transplant allocation policy, which appears to be successfully directing organs to those more at risk of dying on the waiting list and with higher survival benefit, have rendered the findings of Liou’s work irrelevant.

“Because uncritical acceptance of the study results by third party payers, referring physicians, and lung transplant centers could place children with cystic fibrosis who would likely benefit from lung transplants at risk, we appreciate Pediatric Transplantation providing this opportunity to rapidly publish an independent critique of the article,” says Dr. Sweet.

Source: Wiley

Related stories:

New clinical trial for patients with asbestos-associated lung cancer
The Mesothelioma Center within the Herbert Irving Comprehensive Cancer Center at NewYork-Presbyterian Hospital and Columbia University Medical Center is now recruiting patients for a clinical research study of a new targeted radiation and chemotherapy protocol for pleural mesothelioma, a cancer of the lung's lining that is almost always caused by previous exposure to asbestos.
Study finds good outcomes for older lung transplant patients
In the world of organ donation, it has been common practice to exclude older patients from receiving transplants because of limited donor supply and lower survival rates. However, patients such as Lois Tumanello, who received a successful lung transplant at 65, are proving that perhaps age does not always matter.
Heart transplants: Do more or do none, study suggests
Heart surgeons at Johns Hopkins have evidence to support further tightening rather than easing of standards used to designate hospitals that are best at performing heart transplants.
Downsized heart aids bypass surgery
An estimated one in 20 patients undergoing a common operation to boost blood supply to the heart and to ward off repeat heart attacks may do better if their surgeons also remold the heart to a near normal size, by cutting and suturing together stretched muscle and scar tissue resulting from the initial attack, according to cardiac surgeons at Johns Hopkins.
Creating lung cancer risk models for specific populations refines prediction
Lung cancer risk prediction models are enhanced by taking into account risk factors by race and by measuring DNA repair capacity, according to research teams led by epidemiologists at The University of Texas M. D. Anderson Cancer Center in two complementary papers appearing in the September issue of Cancer Prevention Research.
OU researchers developing new tool to detect cancer
Early cancer detection can significantly improve survival rates. Current diagnostic tests often fail to detect cancer in the earliest stages and at the same time expose a patient to the harmful effects of radiation. Led by Dr. Patrick McCann, a small group of internationally known researchers at the University of Oklahoma with expertise in the development of mid-infrared lasers is working to create a sensor to detect biomarker gases exhaled in the breath of a person with cancer.
Researchers uncover cancer survival secrets
A team of Monash University researchers has uncovered the role of a family of enzymes in the mutation of benign or less aggressive tumours into more aggressive, potentially fatal, cancers in the human body.
Cancer patients are not given enough information
Two thirds of cancer patients receive little or no information about the survival benefits of having palliative chemotherapy before making a decision about treatment, according to a study published today on bmj.com.

News discussion:

Medicine & Health news